News & Updates

Researchers from a joint team at the University of Hong Kong (HKU) and Chinese Academy of Sciences have developed a novel neutralizing monoclonal antibody (mAb; 6H2) that targets circulating adipocyte fatty acid–binding protein (A-FABP), offering potential in alleviating cerebral ischaemic injury.

Renal denervation yields substantial reductions in ambulatory systolic blood pressure for up to 36 years in randomized controlled trials and up to 10 years in observational cohort studies without compromising renal function, according to the results of a systematic review and meta-analysis.

Adding pembrolizumab to standard chemotherapy resulted in a favourable overall survival (OS) benefit in patients with advanced or recurrent endometrial cancer compared with chemotherapy alone, regardless of mismatch repair (MMR) status, according to a key prespecified secondary analysis of the NRG-GY018 trial presented at the SGO 2024.

Very elderly patients with nonvalvular atrial fibrillation fare well with either edoxaban or apixaban in terms of stroke prevention, although those on edoxaban may have higher bleeding risk, according to a study.

A recent study has found that genetically predicted higher plasma caffeine concentrations can lower the risk of inflammatory bowel disease (IBD), including its subtypes.

People who refused to be vaccinated against COVID-19 appear to be at significantly greater risks of a traffic accident, reports a study.

Many adult survivors of childhood cancer do not adhere to a healthful dietary pattern, particularly racial minorities and those with a lower socioeconomic status, reveals a study.

In patients undergoing fixation of a closed lower limb or pelvic fracture, iodine povacrylex in alcohol appears to be a better option than chlorhexidine gluconate (CHG) in alcohol as preoperative skin antiseptic to prevent surgical site infection (SSI). Among those with open upper limb or lower limb fracture, outcomes were similar for both solutions, the PREPARE* trial suggests.